Corient Capital Partners, LLC United Therapeutics Corp Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Corient Capital Partners, LLC holds 930 shares of UTHR stock, worth $372,418. This represents 0.02% of its overall portfolio holdings.
Number of Shares
930
Previous 930
-0.0%
Holding current value
$372,418
Previous $219,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
665Shares Held
43MCall Options Held
292KPut Options Held
341K-
Black Rock Inc. New York, NY5.47MShares$2.19 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.77 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.27 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.14 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$896 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $18.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...